 |
| |
2011 |
|
Successful delivery of early milestones in drug discovery
with AstraZeneca
Late stage discovery milestone in oncology program with Endo
Pharmaceuticals
Receives USFDA approval for Donepezil Hydrochloride tablets
5mg & 10 mg
Sets up global scale capacities for Symtet developed
through inhouse R&D
|
|
|
|
| |
2010 |
|
Jubilant Life Sciences (JLL) demerges its Agri &
Performance Polymers; business to Jubilant Industries Limited
(JIL)
Jubilant Organosys Limited changes to Jubilant
Life Sciences Limited
Board approves scheme of amalgamation & demerger
Strengthens global leadership position in vitamin B3
|
|
|
 |
| |
2009 |
|
Inauguration of Jubilant Kalpataru hospital at Barasat,
KOLKATA,
Extend drug discovery collaboration with Lilly on successful
delivery of pre-clinical candidates
Enter into drug discovery joint venture with UAB and Southern
Research in the US
Intent to enter global research and drug development
partnership with Duke University
To work with Endo Pharmaceuticals on drug development
Enters Research collaboration with AstraZeneca research
collaboration to provide AstraZeneca with new preclinical drug
candidates
DRAXIMAGE’S generic Sestamibi approved for launch in the
USA, exclusive distribution agreement signed with GE healthcare.
Ink Hybrid and integrated Drug discovery collaboration with
Orion
Receives approval for Sestamibi in Canada
New partnership in drug discovery with Bioleap
|
|
|
|
| |
2008 |
|
Drug Discovery partnership with Amgen Inc, USA
Jubilant Organosys and Lilly to Form Drug Development Joint
Venture, Indian J.V. expands companies drug discovery and
development collaboration
Augments Clinsys Clinical Research® through acquisition of
TrialStat ClinicalAnalytics®, an EDC platform
Acquires DRAXIS Specialty Pharmaceuticals, Inc. Canada, a
contract manufacturer of sterile & non-sterile products and
radiopharmaceuticals
Acquires Speciality Molecules Pvt. Ltd. Engaged in the
manufacturing of Fine Chemicals used by Life Science Industry
including pharma, agro & cosmetic industry
|
|
|
|
| |
2007 |
|
Acquires Hollister Stier Laboratories in USA, a contract
manufacturer of Sterile injectable vials and allergenic
extracts.
|
|
|
|
| |
2005
|
|
Acquired pharmaceutical company in USA involved in off patent
drug development and supply, and owns US FDA approved
manufacturing facility for solid dosage forms.
Acquires full service Clinical Research Organization in USA
involved in providing clinical research services, data
management, biostatistics and contract staffing.
Acquires Target Research Associates, Inc., renamed Clinsys
Inc.; a US based Clinical Research Organisation (CRO)
Acquires Trinity Laboratories, Inc. and its wholly owned
subsidiary, Trigen Laboratories, Inc., renamed Jubilant
Pharmaceuticals, Inc., a generic pharmaceutical company in USA
having a US FDA approved formulations manufacturing facility
Enters Clinsys Clinical Research Ltd. business by setting up
wholly owned subsidiary Jubilant Clinsys Ltd.
|
|
|
|
| |
2004
|
|
Enters the medicinal chemistry arena by setting up Jubilant
Chemsys.
Set up a Contract Clinical Research Organization named Jubilant
Clinsys to conduct bioavailability, bioequivalence,
pharmacokinetic and phase 1 studies.
Sets up medicinal chemistry services business through wholly
owned subsidiary Jubilant Chemsys Ltd.
Enters formulations and regulatory affairs businesses by
acquiring Pharmaceuticals Services Incorporated, N.V. and PSI
Supply N.V., the pharmaceutical companies in Europe.
|
|
|
|
| |
2003 |
|
Sets up a new state-of-the-art Research & Development
Centre in Noida, near New Delhi equipped with all latest
scientific instruments.
|
|
|
|
| |
2002 |
|
Acquires the Active Pharmaceutical Ingredients business
|
|
|
|
| |
2001 |
|
New corporate identity: Jubilant Organosys Ltd. reflecting
changed corporate and business profile
|
|
|
|
| |
2000 |
|
Enters the Bio / chemo informatics arena by setting up Jubilant
Biosys Ltd.
|
|
|
|
| |
1998 |
|
Enters high value-added Pyridine derivates. Commissions
Pyridine HBR and Cyano Pyridine plants.
Forms marketing subsidiary in the USA.
Acquires acetyl plant in western India.
|
|
|
|
| |
1997
|
|
Commissions first Multi-purpose fine chemicals plant. Plant for
food polymer commissioned.
|
|
|
|
| |
1995
|
|
Gets ISO 9001 certification.
|
|
|
|
| |
1990
|
|
Commissions Pyridine & Picoline plant.
|
|
|
|
| |
1988
|
|
Launches its first branded product: Vamicol, an adhesive
product.
|
|
|
|
| |
1987
|
|
Introduces new products in Performance Chemicals segments: Poly
vinyl acetate emulsion for paint, textile, paper & packaging
and woodworking industry.
|
|
|
|
| |
1985
|
|
Research & Development center gets recognition from
Government of India.
|
|
|
|
| |
1983
|
|
Commercial production of Vinyl Acetate Monomer (VAM).
|
|
|
|
| |
1981
|
|
Initial Public Offering. Listing on leading stock exchanges of
India.
|
|
|
|
| |
1978
|
|
Incorporated as Vam Organic Chemicals Ltd.
|
|
|
|
